Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2375]

Pharmacology update from ONS 2019

Teresa Knoop - Vanderbilt Ingram Cancer Center, Brentwood, USA

Pharmacology update from ONS 2019 ( Teresa Knoop - Vanderbilt Ingram Cancer Center, Brentwood, USA )

Checkpoint inhibitor induced Guillain-Barré syndrome

Jessica Edwards - The Ohio State University James Cancer Hospital, Ohio, USA

Checkpoint inhibitor induced Guillain-Barré syndrome ( Jessica Edwards - The Ohio State University James Cancer Hospital, Ohio, USA )

Long-term safety of niraparib maintenance treatment in patients with recurrent...

Lisa Marie Juden - Dana-Farber Cancer Institute, Boston, MA

Long-term safety of niraparib maintenance treatment in patients with recurrent ovarian cancer ( Lisa Marie Juden - Dana-Farber Cancer Institute, Boston, MA )

Treating ovarian cancers with PARP inhibitors

Lisa Marie Juden - Dana-Farber Cancer Institute, Boston, MA

Treating ovarian cancers with PARP inhibitors ( Lisa Marie Juden - Dana-Farber Cancer Institute, Boston, MA )

Managing the side effects of CAR T-cell therapy

Misty Lamprecht - The Ohio State University James Cancer Hospital, Ohio, USA

Managing the side effects of CAR T-cell therapy ( Misty Lamprecht - The Ohio State University James Cancer Hospital, Ohio, USA )

Updates in surgical oncology

Lisa Parks - The Ohio State University James Cancer Hospital, Columbus, USA

Updates in surgical oncology ( Lisa Parks - The Ohio State University James Cancer Hospital, Columbus, USA )

Evidence-based radiation side effect management

John Hillson - Duke Cancer Institute, Durham, USA

Evidence-based radiation side effect management ( John Hillson - Duke Cancer Institute, Durham, USA )

Clinical photography in cancer care

John Hillson - Duke Cancer Institute, Durham, USA

Clinical photography in cancer care ( John Hillson - Duke Cancer Institute, Durham, USA )

Current treatment for brain tumours

Prof Mark Beresford - Royal United Hospital Bath, Bath, UK

Current treatment for brain tumours ( Prof Mark Beresford - Royal United Hospital Bath, Bath, UK )

The Brain Tumour Charity

Ms Erica Moyes - The Brain Tumour Charity, Farnborough, UK

The Brain Tumour Charity ( Ms Erica Moyes - The Brain Tumour Charity, Farnborough, UK )

Talimogene laherparepvec combined with neoadjuvant chemotherapy for non...

Dr Hatem Soliman - Moffitt Cancer Centre, Tampa, USA

Talimogene laherparepvec combined with neoadjuvant chemotherapy for non-metastatic triple negative breast cancer ( Dr Hatem Soliman - Moffitt Cancer Centre, Tampa, USA )

TATTON: Osimertinib plus savolitinib for patients with EGFR-mutant, MET...

Prof Lecia Sequist - Massachusetts General Hospital, Boston, USA

TATTON: Osimertinib plus savolitinib for patients with EGFR-mutant, MET-amplified NSCLC after progression on EGFR-TKI ( Prof Lecia Sequist - Massachusetts General Hospital, Boston, USA )

More from ecancer